Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/2012
06/14/2012CA2819861A1 Novel modulators and methods of use
06/13/2012EP2461834A2 Metal oxide particles coated with polyethylene glycol and their synthesis
06/13/2012EP1986701B1 Optical agents for use in surgery
06/13/2012EP1615556B1 Method of determining state variables and changes in state variables
06/13/2012EP1615555B1 Method for spatially resolved determination of magnetic particle distribution in an area of examination
06/13/2012EP1410014B2 Method for sample identification in a mammal as well as a kit for performing this method
06/13/2012CN102497888A Perfluoro compounds for use in imaging
06/13/2012CN102492713A Consruction and purposes of mouse pTarget/mutated-LPL super expression vector
06/13/2012CN102492686A Kctd10 gene knock-out mouse model, construction method and application thereof
06/13/2012CN102488904A Gastric mucosa targeting super-paramagnetic magnetic resonance contrast medium composition and preparation method thereof
06/13/2012CN101352351B Method for detecting a brain region with neurodegenerative change
06/12/2012US8198508 Reducing the risk of human anti-human antibodies through V gene manipulation
06/12/2012US8197796 Biocompatible polymeric contrast agents and radiopaque materials for medical devices
06/12/2012US8197795 Measuring amount of Choline present in tissue adjoining or surrounding cancerous tissue before and after treatment by Magnetic Resonance Spectroscopy (MRS), after administration of angiogenesis inhibitor
06/12/2012US8197794 Core 2 GlcNAc-T inhibitors
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2180473C Cloning and characterization of h.pylori flba gene. production of aflagellate strains
06/10/2012CA2761472A1 Method of altering reaction time
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075241A2 Protease degradable polypeptides and uses thereof
06/07/2012WO2012075075A2 Methods and systems for spatially identifying abnormal cells
06/07/2012WO2012073588A1 Mri contrast agent containing composite particles
06/07/2012WO2012073047A2 Compositions and methods
06/07/2012WO2012072819A1 Agents for the molecular imaging of serine-protease in human pathologies
06/07/2012WO2012047841A3 System and method for electromagnetic imaging and therapeutics using specialized nanoparticles
06/07/2012WO2012027274A3 Compositions and methods for imaging
06/07/2012US20120144511 Muteins of the pyrroline-5-carboxylate reductase 1
06/07/2012US20120144506 Double-fusion human embryonic stem cells, method of making double-fusion human embryonic stem cells, triple-fusion human embryonic stem cells, method of making triple-fusion human embryonic stem cells, and methods of monitoring double-fusion human embryonic stem cells and triple-fusion human embryonic stem cells
06/07/2012US20120144505 Targeted and regional cellular ablation in zebrafish
06/07/2012US20120144504 Caspase-8 and skin disease
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120141382 Aptamer modulators of complement protein c3 and biologically active proteolytic products thereof
06/07/2012US20120141381 Methods For Loading Contrast Agents Into A Liposome
06/07/2012US20120141380 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012US20120141378 Methods for treating chronic kidney disease
06/07/2012US20120141377 Compositions and methods for treating cancer
06/07/2012US20120141375 Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer
06/07/2012CA2824724A1 Methods and systems for spatially identifying abnormal cells
06/06/2012EP2460541A1 Kidney imaging agent comprising genetically modified gelatin
06/06/2012EP2459584A1 Homing peptide for tumor vasculature
06/06/2012EP2459235A2 Perfluoro compounds for use in imaging
06/06/2012EP2459234A2 Manufacture, transport and delivery of material containing highly polarized nuclei
06/06/2012EP2459168A2 Method for the preparation of microparticles with efficient bioactive molecule incorporation
06/06/2012EP2459053A2 Non-invasive in vivo optical imaging method
06/06/2012EP2061814B1 Antibodies and immunoconjugates and uses therefor
06/06/2012EP1863940B1 Method of risk management for patients undergoing natalizumab treatment
06/06/2012EP1799865B1 Methods for the administration of iloperidone
06/06/2012CN101991868B Sterilizing, disinfecting and skin-moisturizing medical ultrasonic coupling agent and preparation method thereof
06/06/2012CN101912623B Preparation and application of Fe-Gd double-mode magnetic resonance contrast agent with targeting function
06/06/2012CN101708866B Preparation method of superparamagnetic water-soluble manganous ferrite nano-particle
06/05/2012US8195282 Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus
06/05/2012US8192722 Abuse-proof dosage form
06/05/2012US8192720 Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases
06/05/2012US8192719 Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds
06/05/2012US8192717 Composition for diagnosing amyloid-related diseases
06/05/2012CA2441107C Device and method for the photodynamic diagnosis of tumor tissue
06/05/2012CA2249352C Immunoliposomes that optimize internalization into target cells
05/2012
05/31/2012WO2012070893A2 Single nanoparticle having a nanogap between a core material and a shell material, and manufacturing method thereof
05/31/2012WO2012070712A1 Novel gadolinium chelate of cyclic structure containing ferrocene
05/31/2012WO2012070681A1 Water-soluble hyperbranch polymer having paramagnetism
05/31/2012WO2012003334A3 Molecular probes for imaging of myelin
05/31/2012WO2011163136A3 Tuned multifunctional magnetic nanoparticles for biomedicine
05/31/2012WO2011147926A3 Magnetically responsive membrane structures
05/31/2012WO2011135101A3 Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
05/31/2012US20120137378 Extraneous agents testing
05/31/2012US20120135071 Abuse-proofed dosage form
05/31/2012US20120134933 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine
05/31/2012US20120134932 Manganese-Oxo Clusters as Contrast Agents for Magnetic Resonance Imaging
05/31/2012US20120134931 Peptides whose uptake in cells is controllable
05/31/2012US20120134930 Pyrazine Derivatives for Bioconjugation
05/31/2012US20120134929 Treatment of macrophage-related disorders
05/31/2012US20120134928 Modulation of terminase activity at telomeres and dna double-strand breaks
05/31/2012US20120134927 Beta cell marker antibody
05/31/2012US20120134926 Charge-dynamic polymers and delivery of anionic compounds
05/31/2012US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof
05/31/2012US20120134924 Micro-Vesicles Providing Contrast To Target Tissue Electrical Property Gradients
05/31/2012US20120134922 Peptides whose uptake in cells is controllable
05/31/2012US20120134921 Solid compositions comprising 5-aminolevulinic acid
05/31/2012DE102010052613A1 Heavy atoms containing substance, useful in a medical procedure, which is radiation therapy, preferably X-rays, for the treatment of tumors and to increase the biological effect of radiation, preferably X-rays
05/30/2012EP2457594A1 Cest systems exhibiting a concentration independent responsiveness
05/30/2012EP2456467A1 -polylysine conjugates and use thereof
05/30/2012EP2456357A1 Apparatus and method for influencing and/or detecting magnetic particles
05/30/2012CN102481381A 用于诊断成像的纳米颗粒造影剂 Nanoparticle contrast agents for diagnostic imaging
05/30/2012CN102481380A 体内肿瘤血管系统成像 In vivo imaging of tumor vasculature
05/30/2012CN102477444A 一种细胞骨架结合蛋白wdr1基因敲除模型的建立及其用途 A cytoskeletal protein binding to establish their uses wdr1 knockout models
05/30/2012CN102078617B Method for synthesizing mesoporous silica-based nanocomposite embedded with gold nanorods
05/30/2012CN101912622B Targeted micro-bubble probe for magnetic resonance imaging and blood pressure monitoring and preparation method thereof
05/30/2012CN101863788B 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
05/30/2012CN101814352B Water-soluble rock salt type CoO nano flower-like magnetic particles and application thereof
05/30/2012CN101780284B Magnetic molecular targeted ultrasound contrast agent microsphere and preparation method thereof
05/30/2012CN101773675B Liquid fluorocarbon supported polymer nanometer ultrasonic imaging vesicle and preparation method thereof
05/30/2012CN101703785B Amphipathic super-paramagnetic and magnetically resonant contrast agent and preparation method thereof
05/30/2012CN101687803B Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof
05/30/2012CN101631501B Method of controlling a release of a material carried by ultrasound sensitive particles
05/30/2012CN101597323B Radioactive isotope labeling polypeptide for tumor imaging
05/30/2012CN101371800B Sensor permitting detection of a substance in the body of a living being
05/29/2012US8190241 Fluorescence-mediated molecular tomography
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188041 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 354